Method and composition for treating diabetic ketoacidosis
US8980874B2 · kind B2 · utility
4Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 30, 2010 |
| Grant date | Mar 17, 2015 |
| Priority date | — |
| Expiry date | Feb 4, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating diabetic ketoacidosis are disclosed. The methods utilize an endothelin antagonist to treat diabetic ketoacidosis in mammals, including humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.